Evidence map›Paper›PMID 24711418›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Distinct phosphatases antagonize the p53 response in different phases of the cell cycle.

Indra A Shaltiel, Melinda Aprelia, Adrian T Saurin, Dipanjan Chowdhury, Geert J P L Kops, Emile E Voest, René H Medema

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 79 citations in OpenAlex.

  1. PP4 deficiency drives airway epithelial senescence via the PERK-eIF2α-ATF4-p21 axis in severe asthma.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cells · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Indra A ShaltielDivisions of Cell Biology and.
Melinda ApreliaDivisions of Cell Biology and.
Adrian T SaurinDivision of Cancer Research, University of Dundee, Dundee DD1 9SY, United Kingdom;
Dipanjan ChowdhuryDana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215;
Geert J P L KopsCancer Genomics Center, 3584 CG, Utrecht, The Netherlands; andDepartment of Biomedical Genetics, University Medical Center Utrecht, 3584 CG, Utrecht, The Netherlands.
Emile E VoestCancer Genomics Center, 3584 CG, Utrecht, The Netherlands; andMolecular Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands;
René H MedemaDivisions of Cell Biology andCancer Genomics Center, 3584 CG, Utrecht, The Netherlands; and r.medema@nki.nl.
Cancer Genomics Centre · NLHarvard University · USUniversity of Dundee · GB

Funding

Molecular mechanism and relevance of microRNAs in DSB repair pathway choiceR01CA142698 · NCI · DANA-FARBER CANCER INST · PI CHOWDHURY, DIPANJAN · 2010 to 2019
$3.8M
Serum microRNA as biomarker for radiation injury to lung and hematopoietic cellsR01AI101897 · NIAID · DANA-FARBER CANCER INST · PI CHOWDHURY, DIPANJAN · 2012 to 2016
$2.1M
NCI NIH HHS R01 CA142698NCI NIH HHS R01CA142698NIAID NIH HHS R01 AI101897NIAID NIH HHS R01AI101897
6 · The paper itself

Abstract

The basic machinery that detects DNA damage is the same throughout the cell cycle. Here, we show, in contrast, that reversal of DNA damage responses (DDRs) and recovery are fundamentally different in G1 and G2 phases of the cell cycle. We find that distinct phosphatases are required to counteract the checkpoint response in G1 vs. G2. Whereas WT p53-induced phosphatase 1 (Wip1) promotes recovery in G2-arrested cells by antagonizing p53, it is dispensable for recovery from a G1 arrest. Instead, we identify phosphoprotein phosphatase 4 catalytic subunit (PP4) to be specifically required for cell cycle restart after DNA damage in G1. PP4 dephosphorylates Krüppel-associated box domain-associated protein 1-S473 to repress p53-dependent transcriptional activation of p21 when the DDR is silenced. Taken together, our results show that PP4 and Wip1 are differentially required to counteract the p53-dependent cell cycle arrest in G1 and G2, by antagonizing early or late p53-mediated responses, respectively.

Indexed as

Gene Expression Regulation, NeoplasticCell CycleCheckpoint Kinase 2Cyclin B1DNADNA DamageFibroblastsG1 PhaseG2 PhaseHumansLuminescent ProteinsMutationp38 Mitogen-Activated Protein KinasesPhosphoprotein PhosphatasesPhosphorylationProtein Phosphatase 2CCCNB1 protein, humanCheckpoint Kinase 2CHEK2 protein, humanCyclin B1DNALuminescent Proteinsp38 Mitogen-Activated Protein KinasesPhosphoprotein PhosphatasesPPM1D protein, humanProtein Phosphatase 2Cprotein phosphatase 4TelomeraseTERT protein, humanTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID24711418
PMCPMC4034242
OpenAlexW2074292065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.